GLP-1 drugs linked to higher nail disorder rates
A new study found a fourfold increase in onycholysis among users of GLP-1 receptor agonists. Researchers observed a connection between these medications and nail disorders.
Why it matters
This matters for patients using GLP-1 drugs and healthcare providers monitoring side effects. Evidence comes from an observational study.
Population affected
The study included individuals taking GLP-1 receptor agonists, though specific demographics were not detailed in the report.
Common questions
What is onycholysis?
Onycholysis is a condition where the nail separates from the nail bed.
Are GLP-1 drugs commonly used?
Yes, they are prescribed for weight management and diabetes treatment.
Sources
- GLP-1s Linked to Nail Disorders in New Study Medscape · medscape.com
Headlines and links belong to the publishers listed above. The summary above is written by The Health Brief; see how this works.
